To study the feasibility and effects of new imaging agent, 99mTc-Rituximab, for sentinel lymph nodes biopsy (SLNB) of primary breast cancer.SLNB were performed in eighty-five primary breast cancer patients using 99mTc-Rituximab combined with patent blue. Metastases in sentinel lymph nodes were detected with routine pathologic and immunohistochemistry method.The successful rate of SLNB using combining method of 99mTc-Rituximab and patent blue was 96% (82/85). Thirty cases of SLN (37%, 30/82) were metastasis positive, including twenty-four positive cases by HE staining and six by immunohistochemistry method. SLN was the only metastasis lymph nodes in 18/30 cases. One case has false negative SLN metastasis. The sensitivity and accuracy of SLNB...
Suisheng Yang,* Weiyu Bao,* Xiaorong Bai, Chen Gao, Binming Zhang, Zhuanji Jiang Department of Brea...
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-l...
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-l...
To develop a new imaging agent, (99m)Tc-Rituximab, for sentinel lymphoscinti-graphy and investigate ...
The metastatic status of sentinel lymph nodes (SLNs) might be the most important prognostic factor i...
Purpose: We aimed to develop and translate a CD20-antigen-targeted radiopharmaceutical, Technetium-9...
Tc-99m-tilmanocept is a novel radiopharmaceutical for sentinel lymph node (SLN) biopsy in breast can...
Objective: To evaluate the efficacy of SLN biopsy using imaging and gamma probe in breast cancer and...
Purpose: In breast cancer, the single most important prognostic indicator is the axillary nodal stat...
Purpose: Lymphoscintigraphy and sentinel node biopsy has become a standard method for detection of a...
Introduction and objectives: To evaluate the migration of Tc-99m-tilmanocept from the injection site...
BackgroundSentinel lymph node (SLN) surgery is used worldwide for staging breast cancer patients and...
Sentinel lymph nodes biopsy (SLNB) is a critically important technique to determine the metastatic s...
BackgroundThe efficacy of sentinel lymph node (SLN) surgery requires targeted removal of first-drain...
Purpose The usage of radioactive Technetium(99m) (Tc-99m) colloid for the purpose of sentinel lymph ...
Suisheng Yang,* Weiyu Bao,* Xiaorong Bai, Chen Gao, Binming Zhang, Zhuanji Jiang Department of Brea...
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-l...
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-l...
To develop a new imaging agent, (99m)Tc-Rituximab, for sentinel lymphoscinti-graphy and investigate ...
The metastatic status of sentinel lymph nodes (SLNs) might be the most important prognostic factor i...
Purpose: We aimed to develop and translate a CD20-antigen-targeted radiopharmaceutical, Technetium-9...
Tc-99m-tilmanocept is a novel radiopharmaceutical for sentinel lymph node (SLN) biopsy in breast can...
Objective: To evaluate the efficacy of SLN biopsy using imaging and gamma probe in breast cancer and...
Purpose: In breast cancer, the single most important prognostic indicator is the axillary nodal stat...
Purpose: Lymphoscintigraphy and sentinel node biopsy has become a standard method for detection of a...
Introduction and objectives: To evaluate the migration of Tc-99m-tilmanocept from the injection site...
BackgroundSentinel lymph node (SLN) surgery is used worldwide for staging breast cancer patients and...
Sentinel lymph nodes biopsy (SLNB) is a critically important technique to determine the metastatic s...
BackgroundThe efficacy of sentinel lymph node (SLN) surgery requires targeted removal of first-drain...
Purpose The usage of radioactive Technetium(99m) (Tc-99m) colloid for the purpose of sentinel lymph ...
Suisheng Yang,* Weiyu Bao,* Xiaorong Bai, Chen Gao, Binming Zhang, Zhuanji Jiang Department of Brea...
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-l...
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-l...